Medi Assist Ser. (MEDIASSIST)

FairStock Score: 38/100 — MIXED

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

At 44.88 times earnings and 12.38 times book value, the market is asking me to pay a steep premium for Medi Assist. A wonderful business can justify that, but only if the numbers back it up. Sales grew 28.88%, so there is top-line momentum. But the latest quarter tells a worrying story: ₹240 Cr of sales produced just ₹4 Cr of net profit, and reported profit growth is minus 66.97%. That is not compounding earning power; that is a business whose profitability has collapsed. Historical ROE of 22.83% and ROCE of 18.72% look respectable, but at a 12.38 P/B I am being asked to pay for past performance, not present reality. Debt-to-equity of 0.52 is manageable, though I always prefer less leverage. The Piotroski F-score of 4 out of 9 reinforces my unease about financial health. More troubling is promoter holding of just 4.62%. I want owner-operators with significant skin in the game; this is far too little for my comfort. The 52-week range shows Mr. Market was far more enthusiastic at ₹575.55, but at ₹363.50 with a 44.88 P/E and zero dividend yield, I am not being paid to wait. All my returns would depend on a meaningful earnings recovery. Benjamin Graham taught me to focus on margin of safety. I do not see it here. This is a good-looking sales story with broken near-term earnings power. I will watch from the sidelines until profitability and ownership alignment improve.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer